Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
| Vanda Pharmaceuticals Inc. |
| Teva Pharmaceuticals USA, Inc. |
| 1:2019cv00560 |
| March 22, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 12, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 20
SO ORDERED, re (19 in 1:19-cv-00560-CFC, 74 in 1:18-cv-00651-CFC) Stipulation Regarding Consolidation of Cases filed by Vanda Pharmaceuticals Inc. C.A. No. 19-560 (CFC) shall be consolidated with C.A. No. 18-651 (CFC) for all purposes. All filings shall be in C.A. No. 18-651 (CFC). Signed by Judge Colm F. Connolly on 6/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:19-cv-00560-CFC(fms)
|
| Case associated with lead case: Create association to 1:18-cv-00651-CFC. (fms) |
| Filing 19 STIPULATION and [Proposed] Order Regarding Consolidation of Cases by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 18 NOTICE OF SERVICE of (1) Vanda Pharmaceuticals Inc.'s Identifications of Accused Products, (2) Vanda Pharmaceuticals Inc.'s Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information and (3) Plaintiff Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Filing 17 NOTICE OF SERVICE of 1) Defendants Rule 26 Initial Disclosures 2) Defendants Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Pro Hac Vice Attorney Kira A. Davis, Eric A. Stone, Josephine Young, Daniel J. Klein, Nicholas Groombridge, and Jennifer R. Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00560-CFC, 1:19-cv-00685-CFC, 1:19-cv-00926-CFC(nmg) |
|
Filing 16
SO ORDERED, re (15 in 1:19-cv-00560-CFC, 10 in 1:19-cv-00926-CFC, 72 in 1:18-cv-00651-CFC, 76 in 1:18-cv-00689-CFC, 73 in 1:18-cv-00690-CFC, 16 in 1:19-cv-00685-CFC) Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829. Signed by Judge Colm F. Connolly on 6/3/2019. Associated Cases: 1:18-cv-00651-CFC et al.(nmf)
|
| Filing 15 Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 14 STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to May 31, 2019 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
|
SO ORDERED, re (14 in 1:19-cv-00560-CFC, 15 in 1:19-cv-00685-CFC) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to May 31, 2019 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/20/2019. Associated Cases: 1:19-cv-00560-CFC, 1:19-cv-00685-CFC(fms)
|
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
|
SO ORDERED, re (12 in 1:19-cv-00560-CFC, 12 in 1:19-cv-00685-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/9/2019. Associated Cases: 1:19-cv-00560-CFC, 1:19-cv-00685-CFC(fms)
|
|
SO ORDERED, re (11 in 1:19-cv-00685-CFC, 11 in 1:19-cv-00560-CFC) MOTION for Pro Hac Vice Appearance of Attorney Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/9/2019. Associated Cases: 1:19-cv-00560-CFC, 1:19-cv-00685-CFC(fms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 10 ANSWER to #7 Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
|
Filing 9
ORDER, IT IS ORDERED that, on or before May 20, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/20/2019.) Signed by Judge Colm F. Connolly on 4/17/2019. (nmf)
|
| Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Filing 7 ANSWER to #1 Complaint, , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Filing 6 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 3/28/2019, answer due 4/18/2019. (Jacobs, Karen) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 3/25/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vanda Pharmaceuticals Inc. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,149,829. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/7/2019. Date of Expiration of Patent: 1/25/2033.Thirty Month Stay Deadline: 7/31/2021. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2602217.) - filed by Vanda Pharmaceuticals Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
